NID2 and breast cancer: Further analysis was focused on the ITGA1, ITGA4, ITGA9, NID1, and NID2 genes in which we have identified CpGs nonmethylated in normal breast tissues but prone to abnormal hypermethylation in BC, with hypermethylation found in no less than 5% of samples from our collection.